MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/jcrt.jcrt_436_24

Медицинская библиотека · Journal of cancer research and therapeutics · 2026

Enhancing non-invasive colorectal cancer screening with stool DNA methylation markers and light gradient-boosting machine learning.

Zhu Gangfeng, Zhu Yunlong, Lu Zenghong, Zheng Liangjian, Feng Xiaofei, Zhu Rui, Wang Xiangcai, Xu Xueming, Huang Li

СтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

This study evaluated the effectiveness of stool DNA methylation markers Cannabinoid Receptor Type 1 (CNRIP1), Secreted Frizzled-Related Protein 2 (SFRP2), and Vimentin (VIM), along with Fecal Occult Blood Testing (FOBT), in the non-invasive screening for colorectal cancer (CRC), further integrating these markers with the Light Gradient Boosting Machine (LightGBM) machine learning (ML) algorithm.

METHODS

The study analyzed 100 stool samples (50 CRC, 50 normal) to assess the methylation status of CNRIP1, SFRP2, and VIM gene promoters. FOBT was performed in parallel. Diagnostic performance was assessed using Receiver Operating Characteristic (ROC) curve analysis, and a LightGBM-based ML model was developed, incorporating methylation markers and FOBT results.

RESULTS

ROC analysis demonstrated that SFRP2 had the highest diagnostic accuracy with an area under the curve (AUC) of 0.87 (95% confidence interval [CI]: 0.794-0.946) and a sensitivity of 0.88. CNRIP1 and VIM also showed substantial screening effectiveness, with AUC values of 0.83 and 0.80, respectively. FOBT, in comparison, had a lower predictive value with an AUC of 0.67. The LightGBM-based ML model significantly outperformed individual markers, achieving a high AUC of 0.95 (95% CI: 0.916-0.991). However, the sensitivity of the ML model was 0.78, suggesting a need for improvement in correctly identifying all CRC cases.

CONCLUSION

Stool DNA methylation markers CNRIP1, SFRP2, and VIM exhibited high sensitivity in non-invasive CRC screening. The integration of these biomarkers with the LightGBM ML algorithm enhanced diagnostic accuracy, offering a promising approach for early CRC detection.

Для цитирования: Zhu Gangfeng, Zhu Yunlong, Lu Zenghong, Zheng Liangjian, Feng Xiaofei, Zhu Rui, Wang Xiangcai, Xu Xueming, Huang Li. Enhancing non-invasive colorectal cancer screening with stool DNA methylation markers and light gradient-boosting machine learning.. Journal of cancer research and therapeutics. 2026. DOI: 10.4103/jcrt.jcrt_436_24.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.